Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 184 of 184 entries
Sorted by: Best Match Show Resources per page
Compromised Conscience: A Scoping Review of Moral Injury Among Firefighters, Paramedics, and Police Officers.

Frontiers in psychology

Lentz LM, Smith-MacDonald L, Malloy D, Carleton RN, Brémault-Phillips S.
PMID: 33868111
Front Psychol. 2021 Mar 31;12:639781. doi: 10.3389/fpsyg.2021.639781. eCollection 2021.

BACKGROUND: Public Safety Personnel (e.g., firefighters, paramedics, and police officers) are routinely exposed to human suffering and need to make quick, morally challenging decisions. Such decisions can affect their psychological wellbeing. Participating in or observing an event or situation...

Cite
Lentz LM, Smith-MacDonald L, Malloy D, et al. Compromised Conscience: A Scoping Review of Moral Injury Among Firefighters, Paramedics, and Police Officers. Front Psychol. 2021;12:639781doi: 10.3389/fpsyg.2021.639781.
Lentz, L. M., Smith-MacDonald, L., Malloy, D., Carleton, R. N., & Brémault-Phillips, S. (2021). Compromised Conscience: A Scoping Review of Moral Injury Among Firefighters, Paramedics, and Police Officers. Frontiers in psychology, 12639781. https://doi.org/10.3389/fpsyg.2021.639781
Lentz, Liana M, et al. "Compromised Conscience: A Scoping Review of Moral Injury Among Firefighters, Paramedics, and Police Officers." Frontiers in psychology vol. 12 (2021): 639781. doi: https://doi.org/10.3389/fpsyg.2021.639781
Lentz LM, Smith-MacDonald L, Malloy D, Carleton RN, Brémault-Phillips S. Compromised Conscience: A Scoping Review of Moral Injury Among Firefighters, Paramedics, and Police Officers. Front Psychol. 2021 Mar 31;12:639781. doi: 10.3389/fpsyg.2021.639781. eCollection 2021. PMID: 33868111; PMCID: PMC8044342.
Copy Download .nbib Format: NLM
Deliberations about clinical pharmacogenetic testing in pediatric oncology.

Personalized medicine

Issa AM, Aboushawareb SA, Eisenstat DD, Guilcher GM, Liu G, Rassekh SR, Strahlendorf C, Tallen G, Tanoshima R, Carleton B.
PMID: 33973801
Per Med. 2021 Jul;18(4):399-405. doi: 10.2217/pme-2020-0120. Epub 2021 May 11.

This article summarizes the background, content and outcomes of a special meeting that was convened among oncologists and scientists to discuss the role of pharmacogenetic (PGx) testing in pediatric clinical oncology practice. This meeting provided an opportunity for what...

Cite
Issa AM, Aboushawareb SA, Eisenstat DD, et al. Deliberations about clinical pharmacogenetic testing in pediatric oncology. Per Med. 2021;18(4):399-405doi: 10.2217/pme-2020-0120.
Issa, A. M., Aboushawareb, S. A., Eisenstat, D. D., Guilcher, G. M., Liu, G., Rassekh, S. R., Strahlendorf, C., Tallen, G., Tanoshima, R., & Carleton, B. (2021). Deliberations about clinical pharmacogenetic testing in pediatric oncology. Personalized medicine, 18(4), 399-405. https://doi.org/10.2217/pme-2020-0120
Issa, Amalia M, et al. "Deliberations about clinical pharmacogenetic testing in pediatric oncology." Personalized medicine vol. 18,4 (2021): 399-405. doi: https://doi.org/10.2217/pme-2020-0120
Issa AM, Aboushawareb SA, Eisenstat DD, Guilcher GM, Liu G, Rassekh SR, Strahlendorf C, Tallen G, Tanoshima R, Carleton B. Deliberations about clinical pharmacogenetic testing in pediatric oncology. Per Med. 2021 Jul;18(4):399-405. doi: 10.2217/pme-2020-0120. Epub 2021 May 11. PMID: 33973801.
Copy Download .nbib Format: NLM
Identification of Drug Transporter Genomic Variants and Inhibitors that Protect Against Doxorubicin-Induced Cardiotoxicity.

Circulation

Magdy T, Jouni M, Kuo HH, Weddle CJ, Lyra-Leite D, Fonoudi H, Romero-Tejeda M, Gharib M, Javed H, Fajardo G, Ross CJD, Carleton BC, Bernstein D, Burridge PW.
PMID: 34874743
Circulation. 2021 Dec 07; doi: 10.1161/CIRCULATIONAHA.121.055801. Epub 2021 Dec 07.

No abstract available.

Cite
Magdy T, Jouni M, Kuo HH, et al. Identification of Drug Transporter Genomic Variants and Inhibitors that Protect Against Doxorubicin-Induced Cardiotoxicity. Circulation. 2021;doi: 10.1161/CIRCULATIONAHA.121.055801.
Magdy, T., Jouni, M., Kuo, H. H., Weddle, C. J., Lyra-Leite, D., Fonoudi, H., Romero-Tejeda, M., Gharib, M., Javed, H., Fajardo, G., Ross, C. J. D., Carleton, B. C., Bernstein, D., & Burridge, P. W. (2021). Identification of Drug Transporter Genomic Variants and Inhibitors that Protect Against Doxorubicin-Induced Cardiotoxicity. Circulation, . https://doi.org/10.1161/CIRCULATIONAHA.121.055801
Magdy, Tarek, et al. "Identification of Drug Transporter Genomic Variants and Inhibitors that Protect Against Doxorubicin-Induced Cardiotoxicity." Circulation vol. (2021). doi: https://doi.org/10.1161/CIRCULATIONAHA.121.055801
Magdy T, Jouni M, Kuo HH, Weddle CJ, Lyra-Leite D, Fonoudi H, Romero-Tejeda M, Gharib M, Javed H, Fajardo G, Ross CJD, Carleton BC, Bernstein D, Burridge PW. Identification of Drug Transporter Genomic Variants and Inhibitors that Protect Against Doxorubicin-Induced Cardiotoxicity. Circulation. 2021 Dec 07; doi: 10.1161/CIRCULATIONAHA.121.055801. Epub 2021 Dec 07. PMID: 34874743.
Copy Download .nbib Format: NLM
SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain.

iScience

Fodoulian L, Tuberosa J, Rossier D, Boillat M, Kan C, Pauli V, Egervari K, Lobrinus JA, Landis BN, Carleton A, Rodriguez I.
PMID: 33251489
iScience. 2020 Dec 18;23(12):101839. doi: 10.1016/j.isci.2020.101839. Epub 2020 Nov 25.

Reports indicate an association between COVID-19 and anosmia, as well as the presence of SARS-CoV-2 virions in the olfactory bulb. To test whether the olfactory neuroepithelium may represent a target of the virus, we generated RNA-seq libraries from human...

Cite
Fodoulian L, Tuberosa J, Rossier D, et al. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain. iScience. 2020;23(12):101839doi: 10.1016/j.isci.2020.101839.
Fodoulian, L., Tuberosa, J., Rossier, D., Boillat, M., Kan, C., Pauli, V., Egervari, K., Lobrinus, J. A., Landis, B. N., Carleton, A., & Rodriguez, I. (2020). SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain. iScience, 23(12), 101839. https://doi.org/10.1016/j.isci.2020.101839
Fodoulian, Leon, et al. "SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain." iScience vol. 23,12 (2020): 101839. doi: https://doi.org/10.1016/j.isci.2020.101839
Fodoulian L, Tuberosa J, Rossier D, Boillat M, Kan C, Pauli V, Egervari K, Lobrinus JA, Landis BN, Carleton A, Rodriguez I. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain. iScience. 2020 Dec 18;23(12):101839. doi: 10.1016/j.isci.2020.101839. Epub 2020 Nov 25. PMID: 33251489; PMCID: PMC7685946.
Copy Download .nbib Format: NLM
Showing 181 to 184 of 184 entries